article nutrient neofusion band niacin band

niacin



















names


preferred iupac name

pyridine3carboxylic acid1




names
nicotinic acid
bionic
vitamin
vitamin



identifiers



number




59676






model jsmol




interactive image





3dmet
b00073



beilstein reference

109591


chebi



chebi15940





chemspider









drugbank



db00627





echa infocard
100000401


number
2004410



gmelin reference

3340



iupharbps




1588





kegg



d00049





mesh
niacin



pubchem










rtecs number
qt0525000


unii



2679mf687a







inchi



inchi1sc6h5no2c8695213745h14hh89
pvniimvlhyawgpuhfffaoysan




inchi1c6h5no2c8695213745h14hh89
pvniimvlhyawgpuhfffaoyaa









smiles


ococ1cccnc1






properties



chemical formula







molar mass
1231094 mol−1


appearance
white translucent crystals


density
1473 cm−3


melting point




solubility water





0219


acidity
20485


isoelectric point




refractive index

14936



dipole moment

01271305813


thermochemistry



enthalpy
formation δfho298

−3449 mol−1



enthalpy
combustion δcho298

−273083 mol−1


pharmacology



code

c04ac01 c10ad02


license data



nicotinic acid






routes
administration

intramuscular oral


pharmacokinetics



biological halflife

20–45


hazards



classification outdated




rphrases outdated
r363738


sphrases outdated



nfpa




















flash point




autoignition
temperature






except otherwise noted data given materials standard state




verify


infobox references






niacin also known nicotinic acid organic compound depending definition used essential human nutrients together nicotinamide makes group known vitamin complex2 formula


belongs group pyridinecarboxylic acids
medication supplemental niacin primarily used treat high blood cholesterol pellagra niacin deficiency insufficient niacin diet cause nausea skin mouth lesions anemia headaches tiredness lack niacin also observed pandemic deficiency disease caused lack five crucial vitamins niacin vitamin thiamin vitamin vitamin usually found areas widespread poverty malnutrition niacin provided diet variety whole processed foods highest contents fortified packaged foods meat various animal sources countries require addition grains3
colorless watersoluble solid derivative pyridine carboxyl group cooh 3position forms vitamin include corresponding amide nicotinamide niacinamide carboxyl group replaced carboxamide group conh
well complex amides variety esters nicotinic acid niacinamide convertible steady world demand rising 8500 tonnes year 1980s 40000 recent years4
niacin cannot directly converted nicotinamide compounds precursors coenzymes nicotinamide adenine dinucleotide nicotinamide adenine dinucleotide phosphate nadp vivo5 converts nadp phosphorylation presence enzyme kinase nadp coenzymes many dehydrogenases participating many hydrogen transfer processes6 important catabolism carbohydrate protein alcohol well cell signaling repair nadp mostly anabolism reactions fatty acid cholesterol synthesis6 high energy requirements brain high turnover rate skin organs usually susceptible deficiency7
niacin supplementation found useful decreasing risk cardiovascular disease already statin8 appears effective taking statin9 although niacin nicotinamide identical vitamin activity nicotinamide pharmacological effects lipid modifying effects niacin nicotinamide reduce cholesterol cause flushing10 precursor nadp niacin also involved repair1112



contents


dietary recommendations

food sources


medical uses

abnormal lipids
treatment deficiency


contraindications
side effects

facial flushing
gastrointestinal hepatic
metabolic

pregnancy


deficiency
pharmacology

pharmacodynamics
pharmacokinetics

biosynthesis




physical chemical properties

laboratory synthesis


preparations

extended release
inositol hexanicotinate
nicotinamide


history
research
references
external links



dietary recommendationsedit
institute medicine updated estimated average requirements ears recommended dietary allowances rdas vitamins 1998 current ears niacin women ages mgday mgday respectively rdas mgday respectively rdas higher ears identify amounts cover people higher average requirements pregnancy mgday lactation mgday infants months adequate intake mgday children ages 1–13 years increases mgday safety sets tolerable upper intake levels vitamins minerals evidence sufficient case niacin mgday collectively ears rdas referred dietary reference intakes dris13
european food safety authority efsa refers collective information dietary reference values population reference intake instead average requirement instead defined united states women including pregnant lactating children niacin megajoule energy consumed conversion 2388 kcal adult consuming 2388 calories consuming niacin comparable rdas14 niacin mgday much less value applies niacin supplement consumed dose intended avoid skin flush reaction explains higher ul15
describe amounts needed niacin equivalents calculated niacin essential amino acid tryptophan amino acid utilized synthesize vitamin1314
food dietary supplement labeling purposes amount serving expressed percent daily value niacin labeling purposes daily value 2016 revised bring agreement rda16 table adult daily values provided reference daily intake original deadline compliance july 2018 september 2017 released proposed rule extended deadline january 2020 large companies january 2021 small companies17
food sourcesedit
niacin found variety whole processed foods including fortified packaged foods meat various animal sources seafoods spices18
among whole food sources highest niacin content grams
meats

cooked skipjack tuna
cooked light meat turkey
cooked lean ground pork
cooked venison
cooked lean veal

plant foods spices

sesame seed flour
ground ginger
dried tarragon
dried green sweet peppers
grilled portabella mushrooms
roasted sunflower seeds
dehydrated apricots
baked potato

fortified breakfast cereals among highest niacin contents grams18 whole grain flours wheat rice barley corn pasta niacin contents range 3–10 grams18
medical usesedit
abnormal lipidsedit
niacin sometimes used addition lipidlowering medications19 systematic reviews found effect niacin cardiovascular disease death spite raising cholesterol reported side effects including increased risk diabetes82021
treatment deficiencyedit
niacin niacinamide used prevention treatment pellagra22
contraindicationsedit
niacin contraindicated active liver disease persistent elevated serum transaminases active peptic ulcer disease arterial bleeding23
side effectsedit
common adverse effects flushing warmth redness itching tingling headache pain abdominal pain diarrhea dyspepsia nausea vomiting rhinitis pruritus rash minimized initiating therapy dosages increasing dosage gradually avoiding administration empty stomach23 high doses niacin often temporarily reduce blood pressure result acute vasodilation24 longer term highdose niacin persistently lower blood pressure individuals hypertension research needed determine extent effect24
facial flushingedit
flushing usually lasts minutes though sometimes last hours sometimes accompanied prickly itching sensation particular areas covered clothing flushing blocked taking aspirin half hour taking niacin taking tablet ibuprofen coadministering prostaglandin receptor antagonist laropiprant taking niacin meals also helps reduce side effect acquired tolerance also help reduce flushing several weeks consistent dose patients longer experience flushing25 reduction flushing focuses altering blocking prostaglandin mediated pathway26 slow sustainedrelease forms niacin developed lessen side effects2728 study showed incidence flushing significantly lower sustainedrelease formulation29 though doses associated liver damage particular slowrelease formulations30
prostaglandin pgd2 primary cause flushing reaction serotonin appearing secondary role reaction31 effect mediated prostaglandin gpr109a activation epidermal langerhans cells keratinocytes3233 langerhans cells cyclooxygenase type cox1 pge2 production responsible acute flushing keratinocytes cox2 dependent active continued vasodilation3435 flushing often thought involve histamine histamine shown involved reaction31
gastrointestinal hepaticedit
gastrointestinal complaints indigestion nausea liver failure also reported hepatotoxicity possibly related metabolism amidation resulting production36 timerelease form lower therapeutic index lowering serum lipids relative form toxicity37
metabolicedit
high doses niacin used improve lipid profile shown elevate blood sugar thereby worsening diabetes mellitus30 niacin therapy increases risk newonset diabetes approximately 3438
hyperuricemia another side effect taking highdose niacin exacerbate gout39
otheredit
side effects heart arrhythmias also reported30page needed increased prothrombin time decreased platelet count reported therefore monitored closely patients also taking anticoagulants23
particularly timerelease variety extremely high doses cause acute toxic reactions40 extremely high doses niacin also cause niacin maculopathy thickening macula retina leads blurred vision blindness maculopathy reversible niacin intake ceases41
pregnancyedit
niacin doses used lower cholesterol levels associated birth defects laboratory animals possible consequences infant development pregnant women30
deficiencyedit
main article pellagra




pellagra caused chronic lack vitamin diet


1906 1940 million americans affected pellagra 100000 deaths joseph goldberger assigned study pellagra surgeon general united states produced good results late 1930s studies spies marion blankenhorn clark cooper established niacin cured pellagra humans disease greatly reduced result
present niacin deficiency sometimes seen developed countries usually apparent conditions poverty malnutrition chronic alcoholism42 also tends occur less developed areas people maize corn staple food maize grain digestible niacin cooking technique called nixtamalization pretreating alkali ingredients increases bioavailability niacin maize mealflour production reason people consume corn tortillas hominy risk niacin deficiency
mild niacin deficiency shown slow metabolism causing decreased tolerance cold
severe deficiency niacin diet causes disease pellagra characterized diarrhea dermatitis dementia well casals necklace lesions lower neck hyperpigmentation thickening skin inflammation mouth tongue digestive disturbances amnesia delirium eventually death left untreated43 common psychiatric symptoms niacin deficiency include irritability poor concentration anxiety fatigue restlessness apathy depression43 studies indicated patients alcoholic pellagra niacin deficiency important factor influencing onset severity condition patients alcoholism typically experience increased intestinal permeability leading negative health outcomes
hartnup disease hereditary nutritional disorder resulting niacin deficiency43 condition first identified 1950s hartnup family london deficit intestines kidneys making difficult body break absorb dietary tryptophan essential amino acid utilized synthesize niacin resulting condition similar pellagra including symptoms scaly rash sensitivity sunlight oral niacin given treatment condition doses ranging 40–200 good prognosis identified treated early43 niacin synthesis also deficient carcinoid syndrome metabolic diversion precursor tryptophan form serotonin
pharmacologyedit
pharmacodynamicsedit
niacins therapeutic effects partly mediated activation proteincoupled receptors including niacin receptor niacr1 niacin receptor niacr2 highly expressed adipose tissue spleen immune cells keratinocytes expected organs liver kidney heart intestine4445 niacr1 niacr2 inhibit cyclic adenosine monophosphate camp production thus breakdown adipose tissue free fatty acids available liver produce triglycerides verylowdensity lipoproteins vldl consequently lowdensity lipoprotein cholesterol3646 decrease free fatty acids also suppress hepatic expression apolipoprotein apoc3 pparg coactivator1b pgc1b thus increase vldl turn reduce production47 also inhibits diacylglycerol acyltransferase2 important hepatic synthesis
mechanism behind increasing totally understood seems done various ways niacin increases apolipoprotein levels anti catabolic effects resulting higher reverse cholesterol transport also inhibits hepatic uptake downregulating production cholesterol ester transfer protein cetp gene48 finally stimulates abca1 transporter monocytes macrophages upregulates peroxisome proliferatoractivated receptor results reverse cholesterol transport49
reduces secondary outcomes associated atherosclerosis density lipoprotein cholesterol lowdensity lipoprotein cholesterol vldlc triglycerides increases high density lipoprotein cholesterol hdl48 despite importance cardiovascular risk factors high associated fewer cardiovascular events independent reduction5051 effects include antithrombotic vascular inflammation improving endothelial function plaque stability52 adipokines adipocytes’ produced mediators adipokines tumor necrosis factor tnfa interleukins chemokines proinflammatory effect others adiponectin antiinflammatory effect regulates inflammatory process decrease vascular progression atherosclerosis53
niacin also appears upregulate brainderived neurotrophic factor bdnf tropomyosin receptor kinase trkb expression54
research able show function niacin pathway lipid metabolism seen vitamin decrease synthesis apobcontaining lipoproteins vldl lipoprotein several mechanisms directly inhibiting action dgat2 enzyme triglyceride synthesis ability bind receptor hcar2 thereby decreasing lipolysis flux liver triglyceride synthesis11 increased apob catabolism hand cholesterol levels increased niacin direct indirect pathways niacin decreases cetp mass activity synergistic effect decrease triglyceride levels indirectly raise cholesterol levels study also able show direct effects beta chain synthase production hepatic uptake apoai also increase cholesterol levels thus affecting pathway reducing lipid levels help reducing cvd55
pharmacokineticsedit




section needs expansion help adding september 2015







niacin serotonin 5hydroxytryptamine melatonin biosynthesis tryptophan


biosynthesisedit
liver synthesize niacin essential amino acid tryptophan requiring tryptophan make niacin56 riboflavin vitamin iron required reactions involved conversion tryptophan
physical chemical propertiesedit
laboratory synthesisedit
several thousand tons niacin manufactured year starting 3methylpyridine
preparationsedit
niacin available prescription product united states dietary supplement prescription products immediate release niacor tablets extended release niaspan 1000 tablets dietary supplement products immediate slow release latter including inositol hexanicotinate57
overthecounter niacin federally regulated united states58 flush” types inositol hexanicotinate contain convertible niacin compounds little clinical efficacy reducing cholesterol levels59
extended releaseedit
prescription extended release niacin niaspan film coating delays release niacin resulting absorption period 8–12 hours extended release formulations generally reduce vasodilation flushing side effects increase risk hepatotoxicity compared immediate release forms6061
formulation laropiprant merck niacin previously approved europe marketed tredaptive laropiprant prostaglandin binding drug shown reduce vasodilatation flushing 7348626364 hps2thrive study65 study sponsored merck showed additional efficacy tredaptive lowering cholesterol used together statin drugs show increase side effects study resulted complete withdrawal tredaptive international market666768
inositol hexanicotinateedit
form dietary supplement inositol hexanicotinate inositol esterified niacin inositols alcohol groups69 usually sold flushfree noflush niacin units 1000 mgtablets capsules sold overthecounter formulation often marketed labeled niacin thus misleading consumers thinking getting active form medication form niacin cause flushing associated immediaterelease products evidence lipidmodifying functions disputed clinical trials date early 1960s dorner welsh late 1970s ziliotto kruse agusti difficult assess todays standards70 last studies affirmed superiority inositol xantinol esters nicotinic acid reducing serum free fatty acid71 studies conducted period found benefit72 studies explain primarily flushfree preparations contain free nicotinic acid recent placebocontrolled trial small n11group results three months 1500 mgday showed trend improvements total cholesterol ldlc hdlc triglycerides73 thus enough evidence recommend treat dyslipidemia
nicotinamideedit
nicotinamide obtained diet present primarily nadp hydrolysed intestine resulting nicotinamide absorbed either following hydrolysis nicotinic acid nicotinamide present nature small amounts unprepared foods niacin present mainly form cellular pyridine nucleotides nadp enzymatic hydrolysis coenzymes occur course food preparation boiling releases total niacin present sweet corn nicotinamide mgkg
nicotinamide toxic liver doses exceeding gday adults74
historyedit
niacin first described chemist hugo weidel 1873 studies nicotine75 original preparation remains useful oxidation nicotine using nitric acid76 first time niacin extracted casimir funk thought thiamine discovered amine group coined term vitamine niacin extracted livers biochemist conrad elvehjem 1937 later identified active ingredient referred pellagrapreventing factor antiblacktongue factor77 soon studies conducted alabama cincinnati spies found nicotinic acid cured sufferers pellagra78
niacin referred vitamin third vitamins discovered historically referred vitamin vitamin ppfactor derived term pellagrapreventive factor79 biological significance nicotinic acid realized thought appropriate choose name dissociate nicotine avoid perception vitamins niacinrich food contains nicotine cigarettes contain vitamins80 resulting name niacin derived nicotinic acid vitamin7981
carpenter found 1951 niacin corn biologically unavailable released alkaline lime water 1182
1955 altschul colleagues described niacin lipid lowering property83 niacin oldest lipid lowering drug
researchedit
animal models vitro niacin produces marked antiinflammatory effects variety tissues including brain gastrointestinal tract skin vascular tissue activation niacr184858687 niacin shown attenuate neuroinflammation efficacy treating neuroimmune disorders multiple sclerosis parkinsons disease8487 unlike niacin nicotinamide activate niacr1 however niacin nicotinamide activate proteincoupled estrogen receptor gper vitro88
referencesedit


nomenclature organic chemistry iupac recommendations preferred names 2013 blue book cambridge royal society chemistry 2014 doi1010399781849733069fp001 isbn 9780854041824
krutmann jean humbert philippe 2010 nutrition healthy skin strategies clinical cosmetic practice springer science business media isbn 9783642122644
fortify food fortification initiative 2017 retrieved april 2017
cantarella gallifuoco malandra martínková spera cantarella 2011 highyield continuous production nicotinic acid nitrile hydrataseamidase cascade reactions using cascade csmrs enzyme microbial technology 345–50 doi101016jenzmictec201012010 pmid 22112948
michael lehninger albert nelson david 2000 lehninger principles biochemistry york worth publishers isbn 1572591536
moat anstey 2011 pellagra review emphasis photosensitivity british journal dermatology 1188–200 doi101111j13652133201010163x pmid 21128910
ishii nishihara 1981 pellagra among chronic alcoholics clinical pathological study necropsy cases journal neurology neurosurgery psychiatry 209–15 doi101136jnnp443209 490893 pmid 7229643
keene price shunshin francis july 2014 effect cardiovascular risk high density lipoprotein targeted drug treatments niacin fibrates cetp inhibitors metaanalysis randomised controlled trials including 117411 patients clinical research g4379 doi101136bmjg4379 4103514 pmid 25038074
bruckert eric labreuche julien amarenco pierre june 2010 metaanalysis effect nicotinic acid alone combination cardiovascular events atherosclerosis atherosclerosis 353–361 doi101016jatherosclerosis200912023 pmid 20079494 retrieved december 2014
jaconello october 1992 niacin versus niacinamide cmaj 1336277 pmid 1393911
kennedy january 2016 vitamins brain mechanisms dose efficacya review nutrients doi103390nu8020068 4772032 pmid 26828517
kirkland 2012 niacin requirements genomic stability mutat 14–20 doi101016jmrfmmm201111008 pmid 22138132
institute medicine 1998 niacin dietary reference intakes thiamin riboflavin niacin vitamin folate vitamin pantothenic acid biotin choline washington national academies press 123–149 isbn 0309065542 retrieved 20170829
overview dietary reference values population derived efsa panel dietetic products nutrition allergies 2017
tolerable upper intake levels vitamins minerals european food safety authority 2006
federal register 2016 food labeling revision nutrition supplement facts labels
changes nutrition facts panel compliance date
niacin content grams select food subset abridged list food groups united states department agriculture agricultural research service usda branded food products database v3641 january 2017 retrieved january 2017
niacin tablet label updated march 2013 page accessed 2016
schandelmaier briel saccilotto arpagaus hemkens nordmann 2017 niacin primary secondary prevention cardiovascular events cochrane database systematic reviews cd009744 doi10100214651858cd009744pub2 pmid 28616955
garg aakash sharma abhishek krishnamoorthy parasuram garg jalaj virmani deepti sharma toishi stefanini giulio kostis john mukherjee debabrata sikorskaya ekaterina february 2017 role niacin current clinical practice systematic review american journal medicine 173–187 doi101016jamjmed201607038 pmid 27793642
niacin niacinamide vitamin medlineplus national library medicine national institutes health 2016 retrieved october 2016
pharmaceuticals niaspan® niacin extendedrelease tablets prescribing information cranbury 2005
bays rader 2009 nicotinic acid niacin lower blood pressure clin pract 151–9 doi101111j17421241200801934x 2705821 pmid 19054161
guidelines niacin therapy treatment elevated lipoprotein rush hemophilia thrombophilia center july 2005 august 2002 retrieved november 2009 facial flushing common side effect niacin therapy usually subsides several weeks consistent niacin
kamanna kashyap 2008 mechanism action niacin american journal cardiology 20b–26b doi101016jamjcard200802029 pmid 18375237
katzung bertram 2006 basic clinical pharmacology york mcgrawhill medical publishing division isbn 0071451536
barter 2006 options therapeutic intervention effective different agents european heart journal supplements f47–f53 doi101093eurheartjsul041
chapman assmann fruchart shepherd sirtori 2004 raising highdensity lipoprotein cholesterol reduction cardiovascular risk role nicotinic acid—a position paper developed european consensus panel hdlc curr opin 1253–68 doi101185030079904125004402 pmid 15324528
brunton laurence lazo john parker keith 2005 goodman gilmans pharmacological basis therapeutics 11th york mcgrawhill isbn 0071422803
papaliodis boucher kempuraj michaelian wolfberg house theoharides december 2008 niacininduced flush involves release prostaglandin mast cells serotonin platelets evidence human cells vitro animal model pharmacol ther 665–72 doi101124jpet108141333 pmid 18784348
benyó gille kero csiky suchánková nüsing moers pfeffer offermanns 2005 gpr109a pumaghm74a mediates nicotinic acidinduced flushing journal clinical investigation 3634–40 doi101172jci23626 1297235 pmid 16322797
benyó gille bennett clausen offermanns 2006 nicotinic acidinduced flushing mediated activation epidermal langerhans cells molecular pharmacology 1844–9 doi101124mol106030833 pmid 17008386
hanson gille zwykiel lukasova clausen ahmed tunaru wirth offermanns 2010 nicotinic acid monomethyl fumarateinduced flushing involves gpr109a expressed keratinocytes cox2dependent prostanoid formation mice journal clinical investigation 2910–9 doi101172jci42273 2912194 pmid 20664170
maciejewskilenoir richman hakak gaidarov behan connolly 2006 langerhans cells release prostaglandin response nicotinic acid journal investigative dermatology 2637–46 doi101038sjjid5700586 pmid 17008871
gille bodor ahmed offermanns 2008 nicotinic acid pharmacological effects mechanisms action annual review pharmacology toxicology 79–106 doi101146annurevpharmtox48113006094746 pmid 17705685
rader calvert hathcock january 1992 hepatic toxicity unmodified timerelease preparations niacin american journal medicine 77–81 doi1010160002934392900187 pmid 1731514
goldie taylor nguyen mccoy zhao preiss february 2016 niacin therapy risk newonset diabetes metaanalysis randomised controlled trials heart british cardiac society 198–203 doi101136heartjnl2015308055 4752613 pmid 26370223
capuzzi morgan brusco intenzo 2000 niacin dosing relationship benefits adverse effects curr atheroscler 64–71 doi101007s118830000096y pmid 11122726
mittal florin perrone delgado osterhoudt 2007 toxicity niacin beat urine drug screening emerg 587–90 doi101016jannemergmed200701014 pmid 17418450
gass 2003 nicotinic acid maculopathy retina philadelphia suppl 500–10 pmid 15035390
pitsavas andreou bascialla bozikas karavatos 2004 pellagra encephalopathy following bcomplex vitamin treatment without niacin psychiatry 91–5 doi10219029xv1gg1u17krgjh pmid 15242145
prakash gandotra singh lakra 2008 rapid resolution delusional parasitosis pellagra niacin augmentation therapy general hospital psychiatry 581–4 doi101016jgenhosppsych200804011 pmid 19061687
soga kamohara takasaki matsumoto saito ohishi hiyama matsuo matsushime furuichi 2003 molecular identification nicotinic acid receptor biochemical biophysical research communications 364–9 doi101016s0006291x03003425 pmid 12646212
wise foord fraser barnes elshourbagy eilert ignar murdock steplewski green brown dowell szekeres hassall marshall wilson pike 2003 molecular identification high affinity receptors nicotinic acid journal biological chemistry 9869–74 doi101074jbcm210695200 pmid 12522134
wanders judd 2011 future gpr109a agonists treatment dyslipidaemia diabetes obesity metabolism 685–91 doi101111j14631326201101400x pmid 21418500
hernandez molusky 2010 regulation hepatic apoc3 expression pgc1β mediates hypolipidemic effect nicotinic acid cell metabolism 411–9 doi101016jcmet201009001 2950832 pmid 20889132
villines gore taylor 2012 niacin evidence clinical future directions current atherosclerosis reports 49–59 doi101007s1188301102121 pmid 22037771
rubic trottmann lorenz 2004 stimulation cd36 effector reverse cholesterol transport atpbinding cassette monocytoid cells niacin biochemical pharmacology 411–9 doi101016jbcp200309014 pmid 15037193
barter gotto larosa maroni szarek grundy kastelein bittner fruchart 2007 cholesterol levels cholesterol cardiovascular events england journal medicine 1301–10 doi101056nejmoa064278 pmid 17898099
jafri alsheikhali karas 2010 metaanalysis statin therapy alter association levels highdensity lipoprotein cholesterol increased cardiovascular risk annals internal medicine 800–8 doi107326000348191531220101221000006 pmid 21173414
charlton witting barter 2010 evidence niacin inhibits acute vascular inflammation improves endothelial dysfunction independent changes plasma lipids arteriosclerosis thrombosis vascular biology 968–75 doi101161atvbaha109201129 pmid 20167660
gustafson 2010 adipose tissue inflammation atherosclerosis journal atherosclerosis thrombosis 332–41 doi105551jat3939 pmid 20124732
doreswamy prakash 2014 biochemical pathways central nervous system neural degeneration niacin deficiency neural regen 1509–1513 doi10410316735374139475 4192966 pmid 25317166 recent evidences suggest niacin administration upregulate expression bdnftrkb present safely raise possibility niacinmediated neural growth bdnftrkb pathway could least partially mediated enhanced hdlc levels
creider hegele september 2012 niacin another look underutilized lipidlowering medication nature reviews endocrinology 517–28 doi101038nrendo201222 pmid 22349076
jacobson 2007 niacin linus pauling institute retrieved march 2008
dunatchik andrew matthew dujovne carlos 20120301 systematic review evidence effectiveness safety waxmatrix niacin formulation journal clinical lipidology 121–131 doi101016jjacl201107003 issn 19332874 pmid 22385545
meyers daniel carr molly park sang brunzell john 20031216 varying cost free nicotinic acid content overthecounter niacin preparations dyslipidemia annals internal medicine 996–1002 doi107326000348191391220031216000009 issn 15393704 pmid 14678919
keenan joseph 20130101 waxmatrix extendedrelease niacin inositol hexanicotinate comparison waxmatrix extendedrelease niacin inositol hexanicotinate noflush niacin persons mild moderate dyslipidemia journal clinical lipidology 14–23 doi101016jjacl201210004 issn 19332874 pmid 23351578
bassan 2012 case immediaterelease niacin heart lung 95–8 doi101016jhrtlng201007019 pmid 21414665
reiche ines westphal sabine martenslobenhoffer jens tröger luley claus bodeböger stefanie 20110101 pharmacokinetics dose recommendations niaspan® chronic kidney disease dialysis patients nephrology dialysis transplantation official publication european dialysis transplant association european renal association 276–282 doi101093ndtgfq344 issn 14602385 pmid 20562093
lepeleire crumley wenning michiels vets oneill wagner gottesdiener 2007 suppression niacininduced vasodilation antagonist prostaglandin receptor subtype clinical pharmacology therapeutics 849–57 doi101038sjclpt6100180 pmid 17392721
paolini bays ballantyne davidson pasternak maccubbin norquist waters kuznetsova sisk mitchel november 2008 extendedrelease niacinlaropiprant reducing niacininduced flushing better realize benefit niacin improving cardiovascular risk factors cardiol clin 547–60 doi101016jccl200806007 pmid 19031552
kamanna kashyap 2008 nicotinic acid recent developments current opinion cardiology 393–8 doi101097hco0b013e3283021c82 pmid 18520725
treatment reduce incidence vascular events hps2thrive full text view clinicaltrialsgov clinicaltrialsgov retrieved 20170220
medscape medscape access
nainggolan lisa 20130111 niacinlaropiprant products suspended worldwide medscape retrieved 20170220
merck begins overseas recall cholesterol drug reuters january 2013
aguilar charrondiere dusemund galtier gilbert gott grilli guertler kass koenig lambré larsen leblanc mortensen parentmassin pratt imcm rietjens stankovic tobback verguieva woutersen 2009 inositol hexanicotinate inositol hexaniacinate source niacin vitamin added nutritional purposes food supplements efsa journal 1–20
taheri january 2003 noflush niacin treatment hyperlipidemia medscape retrieved march 2008
kruse kruse raetzer heuck oster schellenberg schlierf 1979 nocturnal inhibition lipolysis nicotinic acid derivatives european journal clinical pharmacology 11–15 doi101007bf00644960 pmid 499296
meyers carr park brunzell 2003 varying cost free nicotinic acid content overthecounter niacin preparations dyslipidemia annals internal medicine 996–1002 doi107326000348191391220031216000009 pmid 14678919
benjó maranhão coimbra andrade favarato molina brandizzi 2006 accumulation chylomicron remnants impaired vascular reactivity occur subjects isolated cholesterol effects niacin treatment atherosclerosis 116–122 doi101016jatherosclerosis200508025 pmid 16458316
knip douek moore gillmor mclean bingley gale 2000 safety highdose nicotinamide review diabetologia 1337–45 doi101007s001250051536 pmid 11126400
weidel 1873 kenntniss nicotins justus liebigs annalen chemie pharmacie 330–349 doi101002jlac18731650212
samuel mcelvain 1941 nicotinic acid organic syntheses collective volume
elvehjem madden strongandd woolley 1938 isolation identification antiblacktongue factor biol chem 137–149
kraut alan joseph goldberger pellagra ashes potomac historynihgov retrieved 20170220
pellagra prevention control major emergencies world health organization world health organization retrieved april 2015
niacin nicotinic acid journal american medical association american medical association march 1942 doi101001jama194202830100053014 retrieved 2016
niacin niacin amide journal american medical association american medical association march 1942 doi101001jama194202830100049011 retrieved 2016
laguna carpenter september 1951 versus processed corn niacindeficient diets nutr 21–8 pmid 14880960
altschul hoffer stephen 1955 influence nicotinic acid serum cholesterol archives biochemistry biophysics 558–9 doi1010160003986155900709 pmid 14350806
offermanns schwaninger 2015 nutritional pharmacological activation hca2 ameliorates neuroinflammation trends 245–255 doi101016jmolmed201502002 pmid 25766751 neuroinflammatory cells express hca2 receptor endogenous neuroprotective ketone body βhydroxybutyrate well drugs dimethyl fumarate nicotinic acid established efficacy treatment experimental stroke respectively review summarizes evidence hca2 involved therapeutic effects nicotinic acid ketone bodies reducing neuroinflammation
chai digby choudhury 2013 gpr109a vascular inflammation curr atheroscler doi101007s1188301303259 3631117 pmid 23526298 gpr109as primary pharmacological ligand clinical niacin used years treatment cardiovascular disease mainly favourable effects plasma lipoproteins
graff fang wanders judd february 2016 antiinflammatory effects hydroxycarboxylic acid receptor metab clin 102–113 doi101016jmetabol201510001 pmid 26773933 hca2 highly expressed immune cells including macrophages monocytes neutrophils dermal dendritic cells among cell types recent studies demonstrate hca2 mediates profound antiinflammatory effects variety tissues
wakade chong december 2014 novel treatment target parkinsons disease neurol 34–38 doi101016jjns201410024 pmid 25455298
santolla francesco lappano rosano abonante maggiolini july 2014 niacin activates protein estrogen receptor gpermediated signalling cell signal 1466–1475 doi101016jcellsig201403011 pmid 24662263


external linksedit

vitamin spectrum
niacin bound proteins












vitamins



soluble








αcarotene
βcarotene
retinol
tretinoin











ergosterol
ergocalciferol




7dehydrocholesterol
previtamin
cholecalciferol
25hydroxycholecalciferol
calcitriol 125dihydroxycholecalciferol
calcitroic acid




dihydroergocalciferol



analogues

alfacalcidol
dihydrotachysterol
calcipotriol
tacalcitol
paricalcitol











tocopherol

alpha
beta
gamma
delta


tocotrienol

alpha
beta
gamma
delta


tocofersolan









naphthoquinone
phylloquinone
menaquinones
menadione
menadiol








water soluble










thiamine


analogues

acefurtiamine
allithiamine
fursultiamine
octotiamine
prosultiamine
sulbutiamine




riboflavin




niacin
nicotinamide




pantothenic acid
dexpanthenol
pantethine




pyridoxine pyridoxal phosphate
pyridoxamine
pyritinol




biotin




folic acid
dihydrofolic acid
folinic acid
levomefolic acid




adenosylcobalamin
cyanocobalamin
hydroxocobalamin
methylcobalamin


choline









ascorbic acid
dehydroascorbic acid








combinations



multivitamins









whoem
‡withdrawn market
clinical trials

†phase
§never phase




















peripheral vasodilators



phenylethanolamine derivatives



isoxsuprine
buphenine
bamethan





alpha blockers



nonselective

tolazoline
phentolamine


selective α1blockers

alfuzosin
doxazosin
prazosin
silodosin
tamsulosin
terazosin







niacin derivatives



niacin
nicotinyl alcohol
inositol nicotinate
ciclonicate





purine derivatives



pentifylline
xantinol nicotinate
pentoxifylline
etofylline nicotinate





ergot alkaloids



ergoloid
nicergoline
dihydroergocristine





peripheral vasodilators



cyclandelate
phenoxybenzamine
vincamine
moxisylyte
bencyclane
vinburnine
sulcotidil
buflomedil
naftidrofuryl
butalamine
visnadine
cetiedil
cinepazide
ifenprodil
azapetine
fasudil

















lipid modifying agents



tract




cholesterol absorption inhibitors npc1l1



ezetimibe
sch48461





bile acid sequestrantsresins



colesevelam
colestilan
colestipol
colestyramine
colextran








liver




statins hmgcoa reductase



atorvastatin
cerivastatin‡
fluvastatin
lovastatin
mevastatin
pitavastatin
pravastatin
rosuvastatin
simvastatin





niacin derivatives



acipimox
aluminium nicotinate
niacin
niceritrol
nicofuranose
nicotinyl alcohol





mttp inhibitors vldl



dirlotapide
lomitapide
mitratapide








blood vessels




fibrates ppar



aluminium clofibrate
bezafibrate
ciprofibrate
clinofibrate
clofibrate‡
clofibride
etofibrate
fenofibrate
gemfibrozil
pemafibrate
ronifibrate
simfibrate





cetp inhibitors



anacetrapib†
dalcetrapib§
evacetrapib§
obicetrapib†
torcetrapib§





pcsk9 inhibitors



alirocumab
bococizumab
evolocumab








combinations



ezetimibeatorvastatin
ezetimibesimvastatin
niacinlaropiprant
niacinlovastatin
niacinsimvastatin









alipogene tiparvovec
azacosterol
azalanstat
benfluorex‡
darapladib§
dextrothyroxine‡
lapaquistat§
magnesium pyridoxal 5phosphate glutamate
meglutol
mipomersen
omega3triglycerides
policosanol
probucol
tiadenol
triparanol‡
volanesorsen†









whoem
‡withdrawn market
clinical trials

†phase
§never phase




















gabaa receptor positive modulators



alcohols



brometone
butanol
chloralodol
chlorobutanol cloretone
ethanol alcohol alcoholic drink
ethchlorvynol
isobutanol
isopropanol
menthol
methanol
methylpentynol
pentanol
petrichloral
propanol
tertbutanol 2m2p
tertpentanol 2m2b
tribromoethanol
trichloroethanol
triclofos
trifluoroethanol





barbiturates



dmbb
allobarbital
alphenal
amobarbital
aprobarbital
barbexaclone
barbital
benzobarbital
benzylbutylbarbiturate
brallobarbital
brophebarbital
butabarbitalsecbutabarbital
butalbital
buthalital
butobarbital
butallylonal
carbubarb
crotylbarbital
cyclobarbital
cyclopentobarbital
difebarbamate
enallylpropymal
ethallobarbital
eterobarb
febarbamate
heptabarb
heptobarbital
hexethal
hexobarbital
metharbital
methitural
methohexital
methylphenobarbital
narcobarbital
nealbarbital
pentobarbital
phenallymal
phenobarbital
phetharbital
primidone
probarbital
propallylonal
propylbarbital
proxibarbital
reposal
secobarbital
sigmodal
spirobarbital
talbutal
tetrabamate
tetrabarbital
thialbarbital
thiamylal
thiobarbital
thiobutabarbital
thiopental
thiotetrabarbital
valofane
vinbarbital
vinylbital





benzodiazepines



2oxoquazepam
3hydroxyphenazepam
adinazolam
alprazolam
arfendazam
avizafone
bentazepam
bretazenil
bromazepam
brotizolam
camazepam
carburazepam
chlordiazepoxide
ciclotizolam
cinazepam
cinolazepam
clazolam
climazolam
clobazam
clonazepam
clonazolam
cloniprazepam
clorazepate
clotiazepam
cloxazolam
cp1414s
cyprazepam
delorazepam
demoxepam
diazepam
diclazepam
doxefazepam
elfazepam
estazolam
ethyl carfluzepate
ethyl dirazepate
ethyl loflazepate
etizolam
evt201
fg8205
fletazepam
flubromazepam
flubromazolam
fludiazepam
flunitrazepam
flunitrazolam
flurazepam
flutazolam
flutemazepam
flutoprazepam
fosazepam
gidazepam
halazepam
haloxazolam
iclazepam
imidazenil
irazepine
ketazolam
lofendazam
lopirazepam
loprazolam
lorazepam
lormetazepam
meclonazepam
medazepam
menitrazepam
metaclazepam
mexazolam
midazolam
motrazepam
ndesalkylflurazepam
nifoxipam
nimetazepam
nitrazepam
nitrazepate
nitrazolam
nordazepam
nortetrazepam
oxazepam
oxazolam
phenazepam
pinazepam
pivoxazepam
prazepam
premazepam
proflazepam
pyrazolam
qhii66
quazepam
reclazepam
remimazolam
rilmazafone
ripazepam
ro486791
ro488684
sh053rch32′f
sulazepam
temazepam
tetrazepam
tolufazepam
triazolam
triflubazam
triflunordazepam ro52904
tuclazepam
uldazepam
zapizolam
zolazepam
zomebazam





carbamates



carisbamate
carisoprodol
clocental
cyclarbamate
difebarbamate
emylcamate
ethinamate
febarbamate
felbamate
hexapropymate
lorbamate
mebutamate
meprobamate
nisobamate
pentabamate
phenprobamate
procymate
styramate
tetrabamate
tybamate





flavonoids



6methylapigenin
ampelopsin dihydromyricetin
apigenin
baicalein
baicalin
catechin

egcg
hispidulin
linarin
luteolin
rcome
skullcap constituents baicalin
wogonin





imidazoles



etomidate
metomidate
propoxate





kava constituents



10methoxyyangonin
11methoxyyangonin
11hydroxyyangonin
desmethoxyyangonin
11methoxy12hydroxydehydrokavain
78dihydroyangonin
kavain
5hydroxykavain
56dihydroyangonin
78dihydrokavain
5678tetrahydroyangonin
56dehydromethysticin
methysticin
78dihydromethysticin
yangonin





monoureides



acecarbromal
apronal apronalide
bromisoval
carbromal
capuride
ectylurea





neuroactive steroids



acebrochol
allopregnanolone brexanolone
alfadolone
alfaxalone
3αandrostanediol
androstenol
androsterone
certain anabolicandrogenic steroids
cholesterol
dhdoc
3αdhp
5αdhp
5βdhp

etiocholanolone
ganaxolone
hydroxydione
minaxolone
org20599
org21465
p1185
pregnanolone eltanolone
progesterone
renanolone
sage105
sage217
sage324
sage516
sage689
sage872
testosterone
thdoc





nonbenzodiazepines



βcarbolines abecarnil
gedocarnil
harmane
sl651498
zk93423


cyclopyrrolones eszopiclone
pagoclone
pazinaclone
suproclone
suriclone
zopiclone


imidazopyridines alpidem

necopidem
saripidem
zolpidem


pyrazolopyrimidines divaplon
fasiplon
indiplon
lorediplon
ocinaplon
panadiplon
taniplon
zaleplon


others adipiplon
cgs8216
cgs9896
cgs13767
cgs20625
cl218872
cp615003
ctp354
elb139
gbld345
imepitoin
jm1232
l838417
lirequinil ro413696
ns2664
ns2710
ns11394
pipequaline
rod188
rwj51204
sb205384
sx3228
tgsc01aa
tp003
tpa023
tp13
u89843a
u90042
viqualine
y23684





phenols



fospropofol
propofol
thymol





piperidinediones



glutethimide
methyprylon
piperidione
pyrithyldione





pyrazolopyridines



cartazolate
etazolate
ici190622
tracazolate





quinazolinones



afloqualone
cloroqualone
diproqualone
etaqualone
mebroqualone
mecloqualone
methaqualone
methylmethaqualone
nitromethaqualone
sl164





volatilesgases



acetone
acetophenone
acetylglycinamide chloral hydrate
aliflurane
benzene
butane
butylene
centalun
chloral
chloral betaine
chloral hydrate
chloroform
cryofluorane
desflurane
dichloralphenazone
dichloromethane
diethyl ether
enflurane
ethyl chloride
ethylene
fluroxene
gasoline
halopropane
halothane
isoflurane
kerosine
methoxyflurane
methoxypropane
nitric oxide
nitrogen
nitrous oxide
norflurane
paraldehyde
propane
propylene
roflurane
sevoflurane
synthane
teflurane
toluene
trichloroethane methyl chloroform
trichloroethylene
vinyl ether





othersunsorted



3hydroxybutanal
αemtbl
aa29504
avermectins ivermectin
bromide compounds lithium bromide potassium bromide sodium bromide
carbamazepine
chloralose
chlormezanone
clomethiazole
deabl
dihydroergolines dihydroergocryptine dihydroergosine dihydroergotamine ergoloid dihydroergotoxine

efavirenz
etazepine
etifoxine
fenamates flufenamic acid mefenamic acid niflumic acid tolfenamic acid
fluoxetine
flupirtine
hopantenic acid
lanthanum
lavender
lignans 4omethylhonokiol honokiol magnolol obovatol
loreclezole
menthyl isovalerate validolum
monastrol
niacin
nicotinamide niacinamide
25435
phenytoin
propanidid
retigabine ezogabine
safranal
seproxetine
stiripentol
sulfonylalkanes sulfonmethane sulfonal tetronal trional
terpenoids borneol
topiramate
valerian constituents isovaleric acid isovaleramide valerenic acid valerenol


unsorted benzodiazepine site positive modulators αpinene
mrk409 mk0343
tcs1105
tcs1205






also receptorsignaling modulators gaba receptor modulators gaba metabolismtransport modulators









retrieved httpsenwikipediaorgwindexphptitleniacinoldid812218954 categories hypolipidemic agentsb vitaminspyridinesgabaa receptor positive allosteric modulatorsaromatic acidshidden categories dates october 2014echa infocard wikidatadrug linkchembox dataarticles containing unverified chemical infoboxeswikipedia articles needing page number citations march 2015articles expanded september 2015all articles expandedarticles using small message boxes
